Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization

(2011) Kristin L. Moffitt et al.   Cell Host & Microbe

Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model

(2011) Julie M. Skinner et al.   VACCINE

Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage

(2011) Roman Prymula et al.   VACCINE

Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta‐Analysis

(2010) Daniel M. Weinberger et al.   CLINICAL INFECTIOUS DISEASES

Increasing Incidence of Empyema Complicating Childhood Community‐Acquired Pneumonia in the United States

(2010) Carlos G. Grijalva et al.   CLINICAL INFECTIOUS DISEASES

Streptococcus pneumoniae: virulence factors and variation

(2010) A.M. Mitchell et al.   CLINICAL MICROBIOLOGY AND INFECTION

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

(2010) Carlos G Grijalva et al.   CURRENT OPINION IN PEDIATRICS

Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]

(2010) Sean T. Duggan   DRUGS

Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens

(2010) Fabrice Godfroid et al.   INFECTION AND IMMUNITY

Occult Pneumococcal Bacteremia

(2010) Mark D. Joffe et al.   PEDIATRIC EMERGENCY CARE

Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use

(2010) T. Pilishvili et al.   PEDIATRICS

Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children

(2010) S. L. Kaplan et al.   PEDIATRICS

Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States

(2010) Jaime L. Rubin et al.   VACCINE

A dynamic model of pneumococcal infection in the United States: Implications for prevention through vaccination

(2010) Thierry Van Effelterre et al.   VACCINE

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae

(2009) R. Dagan   CLINICAL MICROBIOLOGY AND INFECTION

Current knowledge regarding the investigational 13-valent pneumococcal conjugate vaccine

(2009) Ener Cagri Dinleyici et al.   Expert Review of Vaccines

Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects againstStreptococcus pneumoniaeinfection in the lung

(2009) Maria T. Arévalo et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

Immunization with a Combination of Three Pneumococcal Proteins Confers Additive and Broad Protection against Streptococcus pneumoniae Infections in Mice

(2009) K. Wu et al.   INFECTION AND IMMUNITY

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

(2009) Katherine L O'Brien et al.   LANCET

Development of 5-valent conjugate pneumococcal protein A – Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease

(2009) Chun Meng et al.   MICROBIAL PATHOGENESIS

Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis

(2009) Heather E. Hsu et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity

(2009) Nancy Bermal et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Association of Serotype of Streptococcus pneumoniae With Risk of Severe and Fatal Outcome

(2009) Simon Rückinger et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Empyema Hospitalizations Increased in US Children Despite Pneumococcal Conjugate Vaccine

(2009) S. T. T. Li et al.   PEDIATRICS

Continued Impact of Pneumococcal Conjugate Vaccine on Carriage in Young Children

(2009) S. S. Huang et al.   PEDIATRICS

Declining invasive pneumococcal disease mortality in the United States, 1990–2005

(2009) Marifi Pulido et al.   VACCINE

Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection

(2008) Julio Villena et al.   CANADIAN JOURNAL OF MICROBIOLOGY

Changing Epidemiology of Invasive Pneumococcal Disease among White Mountain Apache Persons in the Era of the Pneumococcal Conjugate Vaccine

(2008) Rochelle Lacapa et al.   CLINICAL INFECTIOUS DISEASES

Indirect Effect of 7‐Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members

(2008) Eugene V. Millar et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary:Changing Epidemiology of Invasive Pneumococcal Disease: A Complicated Story

(2008) Steven Black   CLINICAL INFECTIOUS DISEASES

Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United States

(2008) Chiaojung Jillian Tsai et al.   CLINICAL INFECTIOUS DISEASES

Population Snapshot of EmergentStreptococcus pneumoniaeSerotype 19A in the United States, 2005

(2008) Matthew R. Moore et al.   JOURNAL OF INFECTIOUS DISEASES

Increase in the Prevalence of the Newly Discovered Pneumococcal Serotype 6C in the Nasopharynx after Introduction of Pneumococcal Conjugate Vaccine

(2008) Moon H. Nahm et al.   JOURNAL OF INFECTIOUS DISEASES

Prevalence and risk factors for nasopharyngeal carriage of Streptococcus pneumoniae among adolescents

(2008) D. M. Cardozo et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Impact of conjugate pneumococcal vaccines on antibiotic resistance

(2008) Ron Dagan et al.   LANCET INFECTIOUS DISEASES

FIVE-FOLD INCREASE IN PEDIATRIC PARAPNEUMONIC EMPYEMA SINCE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE

(2008) Debra J. Hendrickson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Safety and immunogenicity of CRM197-conjugated pneumococcal–meningococcal C combination vaccine (9vPnC–MnCC) whether given in two or three primary doses

(2008) Sigurveig Th. Sigurdardottir et al.   VACCINE

Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults

(2008) Jennifer C. Nelson et al.   VACCINE

The changing epidemiology of pneumococcal pulmonary disease in the era of the heptavalent vaccine

(2008) Catherine A. Lexau   Current Infectious Disease Reports

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

(2007) C. Munoz-Almagro et al.   CLINICAL INFECTIOUS DISEASES